Subscribe to Newsletter

Discovery & Development

Discovery & Development Bioprocessing - Upstream & Downstream

Better Bioanalytics = Better Bioprocesses

| Fredrik Sundberg

Are you up-to-date with new analytical platforms that can give you the edge?

Discovery & Development Dosage Forms

Swallowability by Design

| Thomas Hein

Tablets are the most common dosage form, but have you considered all of your options?

Discovery & Development Technology and Equipment

The Science of Insolubility

Experts come together to discuss the chemistry of solubility and the drug delivery solutions of the future for dealing with poorly soluble compounds.

Discovery & Development Drug Delivery

Follicular Drug Delivery: a Root to Success

| Hanzey Yasar, Sarah Gordon, Brigitta Loretz, Kai Schulze, Carlos A Guzman and Claus-Michael lehr

Can hair follicles and nanotechnology help topical drugs overcome the skin barrier?

Discovery & Development Formulation

The Placebo Effect

| David Banks

David Banks offers a warning on using inappropriate lyophilization placebos.

Discovery & Development Formulation

Can Slow and Steady Win the Cancer Race?

| James Strachan

Researchers say cancer should involve more frequent treatment at lower doses.

Discovery & Development Clinical Trials

Breaking the Habit

| James Strachan

With illegal drug use rising, can a cancer drug be repurposed to cure cocaine addiction?

Discovery & Development Business Practice

Using Taylor Dispersion Analysis to determine oligomeric state of insulin

In this article, we take an introductory look at how TDA works, the information it provides and its complementary application to other techniques within the drug development workflow. In addition, example case study data will showcase the performance of TDA relative to dynamic light scattering (DLS) for assessment of the impact of a range of parameters on the monomer-dimer-hexamer equilibrium of insulin.

Discovery & Development Biosimilars

Accelerating the development of generic pharmaceuticals

In this article, triple detection SEC and MDRS are considered within the context of characterizing complex drug formulations, with specific case studies and results illustrating their application.

Discovery & Development Business Practice

Resonant mass measurement as an analytical tool

Predicting and measuring protein aggregation is a critical challenge in the formulation of biopharmaceuticals. This article describes an analytical tool that hits the ‘sweet spot’ of protein aggregation measurement

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register